Girard Partners’s Compugen CGEN Stock Holding History

Girard Partners’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$3K	–	337
2018 Q3	$3K	Buy	+1,000	New	+$3.5K	﹤0.01%	870

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Girard Partners's CGEN Position: Q4 2018 in Review

Girard Partners sold out of Compugen (CGEN) in Q4 2018, closing a stake of 1,000 shares — an estimated $3K sold.

Girard Partners first reported a position in CGEN in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 39 funds tracked by Wall St. Rank hold CGEN as of Q4 2018.

Girard Partners reported no remaining Compugen position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 1,000 Compugen shares in Q4 2018, an estimated $3K.
Girard Partners first reported a position in Compugen in Q3 2018 and held it in 1 quarter.
Girard Partners's Compugen position peaked at $3K in Q3 2018.
39 funds tracked by Wall St. Rank held Compugen as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.